Archive for the ‘unhelpful retraction notices’ Category
Francisco Gómez Camacho has lost an introduction in The Journal of Markets and Morality of a 2005 issue “for improper use of published material without attribution, as well as a a chapter in a collection of 13 scholarly essays by Brill Publishers due to “serious citation issues.”
The introduction — to a translation of another scholars’ work, Luis de Molina’s Treatise on Money — is no longer in the online version of The Journal of Markets and Morality. On the cover page, and in the table of contents, of the treatise, references to the introduction are crossed out. Where it once was in the text — page 5 of the PDF of the treatise — is a short retraction notice:
A 2013 paper on the neurological impact of flavors has been retracted from The Journal of Neuroscience. The retraction notice offers few details (which is typical for the journal), but a statement sent to us by the last author noted that an investigation at the University of Maryland “determined that data fabrication and manipulation have occurred in this study.”
“Gustatory Stimuli Representing Different Perceptual Qualities Elicit Distinct Patterns of Neuropeptide Secretion from Taste Buds” examined the relationship between flavors and neuropeptides, molecules that send signals to the brain.
Here’s the retraction notice:
The 2007 paper from the Journal of Biological Chemistry, “The Interaction of mPar3 with the Ubiquitin Ligase Smurf2 Is Required for the Establishment of Neuronal Polarity,” concerns the role of a protein, mPar3, in neuron development. It has been cited 29 times, according to Thomson Scientific’s Web of Knowledge.
The last author on both papers, however, told us he believed the retractions were the result of “trivial errors.” Although one journal praised him in its retraction note for his “positive engagement,” he said the process left him feeling “disgusted.”
One paper, “Structural Studies on Molecular Interactions between Camel Peptidoglycan Recognition Protein, CPGRP-S, and Peptidoglycan Moieties N-Acetylglucosamine and N-Acetylmuramic Acid,” was withdrawn from the Journal of Biological Chemistry in August 2014.
The second, “Mode of binding of the antithyroid drug propylthiouracil to mammalian haem peroxidases,” was retracted from Acta Crystallographica Section F this month. Here’s the retraction notice: Read the rest of this entry »
The authors of a 2014 study on the biochemical changes that can encourage the progression of cancer have withdrawn the paper from the Journal of Biological Chemistry.
That’s because the retraction note is – as we’ve come to expect from JBC – not very informative.
Here’s the only explanation for the retraction of “The Down Syndrome Cell Adhesion Molecule (DSCAM) Interacts with and Activates Pak”:
The European Ophthalmic Review has retracted a 2014 article about the macular degeneration drug aflibercept without any explanation.
Here’s the retraction notice, such as it is:
An article published earlier this year has been retracted from the Journal of Heat Transfer. But the retraction notice gives no information about what was amiss.
A group of authors have withdrawn a 2011 Journal of Biological Chemistry paper, but then appear to have re-published almost the same paper a month later, only this time with just five of the original nine authors.
The paper, “HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity,” concerns a type of protein regulation important to cardiac stress. Written by researchers at the University of Chicago and the University of Pittsburgh, it has been cited 16 times, according to Thomson Scientific’s Web of Knowledge. It was rated “Exceptional” by a reviewer on the Faculty of 1000 website.